Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v11-EN
Language English English
Date Updated 2019-05-25 2019-03-18
Drug Identification Number 02411628 02411628
Brand name ROSUVASTATIN-5 ROSUVASTATIN-5
Common or Proper name ROSUVASTATIN ROSUVASTATIN
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients ROSUVASTATIN ROSUVASTATIN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-03-13 2019-03-13
Actual start date 2019-03-13 2019-03-13
Estimated end date 2019-05-24 2019-05-24
Actual end date 2019-05-24
Shortage status Resolved Actual shortage
Company comments Temporarily unavailable Temporarily unavailable
Health Canada comments